Up to 10-15 percent of adrenal cancers arise in patients with a hereditary predisposition to develop cancer. The University of Michigan Endocrine Oncology team has been on the forefront of identifying these inherited conditions. It is standard in the Multidisciplinary Endocrine Oncology Clinic to offer genetic counseling and a complete genetic evaluation to adrenal cancer patients.
If an adrenal nodule is found, the team wants as much information as possible to develop an individualized treatment plan. The team will evaluate the nodule by obtaining a CT scan or MRI done specifically to look at the adrenal glands. Our team prefers to investigate adrenal abnormalities using CT first, and MRI if a different type of study is needed. Patients also have blood drawn and submit urine samples (drawn over 24 hours) to test for excess amounts of adrenal hormones. Other laboratory studies may be obtained depending on individual patient findings.
In general, the five year survival rate for all patients diagnosed with adrenocortical carcinoma approaches 50%. When including those unable to undergo surgery, five year survival rates decrease to approximately 35%. Five year survival rates are different depending on the Stage of the tumor. Not all tumors in each Stage have the same outcome. Each patient’s tumor is different. At the University of Michigan, we treat the individual patient, personalizing their medical care, as we understand that all tumors act
In order to understand adrenal cancer and adrenal tumors, it's important to learn about the adrenal gland, in general.
What Are the Adrenal Glands?
Each person is usually born with two adrenal glands. The adrenals are paired, goldenrod-yellow colored glands that are situated behind the organs of the gastrointestinal tract next to the spine and just above the kidneys in a space called the retroperitoneum.
Adrenal cancer is rare. Exceptional patient care and innovative treatment for adrenal cancer shouldn't be. Contact us at 734-647-8902.
Our clinic brings experts in related fields together to provide coordinated, exceptional patient care to those diagnosed with adrenocortical carcinoma or adrenal cancer. Patients benefit from the experience and expertise of many physicians, not just one.
At the University of Michigan Rogel Cancer Center, adrenal tumors and adrenal cancer are treated by a multidisciplinary team made up of endocrinologists, surgeons, medical oncologists, radiation oncologists, nurses and more. Request an appointment: 734-647-8902
Holistic Approach to Brain and Spinal Cord Cancer Care
The U-M Rogel Cancer Center Neuro-Oncology Program takes a holistic approach to brain and spinal cord tumor care. We offer extensive resources and support services to help control symptoms, manage treatment side effects, and provide educational support to answer your questions and help you understand what to expect. We’re here to assist patients and their families with any physical, mental, and spiritual health needs to maintain their quality of life.
Clinical Trials May Offer the Most Advanced Treatments
The Neuro-Oncology Program at the U-M Rogel Cancer Center has a number of clinical trials underway that are only available to our patients. We have extensive experience in selecting the right trial for individuals.
Participating in a clinical trial may offer you access to the most advanced treatments. In addition, participation offers the opportunity to contribute to treatment advances for all patients — including those who will be treated in the future.
MENU